Makri E - Search Results

1

Comparing the compliance to a short schedule of subcutaneous immunotherapy and to sublingual immunotherapy during three years of treatment.

Manzotti G, Riario-Sforza GG, Dimatteo M, Scolari C, Makri E, Incorvaia C. Manzotti G, et al. Among authors: makri e. Eur Ann Allergy Clin Immunol. 2016 Nov;48(6):224-227. Eur Ann Allergy Clin Immunol. 2016. PMID: 27852426 Free article. Clinical Trial.

2

Subcutaneous and sublingual allergen-specific immunotherapy: a tale of two routes.

Incorvaia C, Ciprandi G, Nizi MC, Makri E, Ridolo E. Incorvaia C, et al. Among authors: makri e. Eur Ann Allergy Clin Immunol. 2020 Nov;52(6):245-257. doi: 10.23822/EurAnnACI.1764-1489.150. Epub 2020 Nov 3. Eur Ann Allergy Clin Immunol. 2020. PMID: 32372588 Free article. Review.

3

Pharmacodynamic and pharmacokinetic evaluation of house dust mite sublingually administered immunotherapy tablet in the treatment of asthma.

Mauro M, Boni E, Makri E, Incorvaia C. Mauro M, et al. Among authors: makri e. Expert Opin Drug Metab Toxicol. 2015;11(12):1937-43. doi: 10.1517/17425255.2015.1113255. Epub 2015 Nov 13. Expert Opin Drug Metab Toxicol. 2015. PMID: 26565665 Review.

4

Risk of anaphylaxis in patients with large local reactions to hymenoptera stings: a retrospective and prospective study.

Pucci S, D'Alò S, De Pasquale T, Illuminati I, Makri E, Incorvaia C. Pucci S, et al. Among authors: makri e. Clin Mol Allergy. 2015 Nov 9;13:21. doi: 10.1186/s12948-015-0030-z. eCollection 2015. Clin Mol Allergy. 2015. PMID: 26557045 Free PMC article.

5

Comparing the ability of molecular diagnosis and CAP-inhibition in identifying the really causative venom in patients with positive tests to Vespula and Polistes species.

Savi E, Peveri S, Makri E, Pravettoni V, Incorvaia C. Savi E, et al. Among authors: makri e. Clin Mol Allergy. 2016 Feb 8;14:3. doi: 10.1186/s12948-016-0040-5. eCollection 2016. Clin Mol Allergy. 2016. PMID: 26858583 Free PMC article.

6

Striving for optimal bronchodilation: focus on olodaterol.

Incorvaia C, Montagni M, Makri E, Riario-Sforza GG, Ridolo E. Incorvaia C, et al. Among authors: makri e. Int J Chron Obstruct Pulmon Dis. 2016 Mar 1;11:439-44. doi: 10.2147/COPD.S96070. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27042036 Free PMC article. Review.

7

New combinations in the treatment of COPD: rationale for aclidinium-formoterol.

Incorvaia C, Montagni M, Makri E, Ridolo E. Incorvaia C, et al. Among authors: makri e. Ther Clin Risk Manag. 2016 Feb 15;12:209-15. doi: 10.2147/TCRM.S82034. eCollection 2016. Ther Clin Risk Manag. 2016. PMID: 26929634 Free PMC article. Review.

8

Current treatment strategies for seasonal allergic rhinitis: where are we heading?

Ridolo E, Incorvaia C, Pucciarini F, Makri E, Paoletti G, Canonica GW. Ridolo E, et al. Among authors: makri e. Clin Mol Allergy. 2022 Aug 10;20(1):9. doi: 10.1186/s12948-022-00176-x. Clin Mol Allergy. 2022. PMID: 35948975 Free PMC article. Review.

9

Two decades with omalizumab: what we still have to learn.

Incorvaia C, Mauro M, Makri E, Leo G, Ridolo E. Incorvaia C, et al. Among authors: makri e. Biologics. 2018 Oct 26;12:135-142. doi: 10.2147/BTT.S180846. eCollection 2018. Biologics. 2018. PMID: 30464389 Free PMC article. Review.

10

Asthma associated to rhinitis.

Incorvaia C, Masieri S, Cavaliere C, Makri E, Sposato B, Frati F. Incorvaia C, et al. Among authors: makri e. J Biol Regul Homeost Agents. 2018 Jan-Feb;32(1 Suppl. 1):67-71. J Biol Regul Homeost Agents. 2018. PMID: 29552876 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters